Glucagon Market Report

Glucagon Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 23, 2020
  • PAGES：205
  • REPORT CODE：GMM482390
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Glucagon market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1%% during the forecast period.

    This report presents the market size and development trends by detailing the Glucagon market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Glucagon market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Glucagon industry and will help you to build a panoramic view of the industrial development.

    Glucagon Market, By Type:

    • Inject Glucagon

    • Nasal Glucagon

    Glucagon Market, By Application:

    • Emergency Kits

    • General Use

    • Diagnostic & Motility

    • Cardiogenic Shock

    • Others

    Some of the leading players are as follows:

    • Torrent Labs

    • Eli Lilly

    • Xeris Pharmaceuticals

    • Novo Nordisk

    • Fresenius Kabi

    • Taj Pharmaceuticals

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Glucagon Market: Technology Type Analysis

    • 4.1 Glucagon Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Glucagon Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Inject Glucagon

      • 4.3.2 Nasal Glucagon

    5 Glucagon Market: Product Analysis

    • 5.1 Glucagon Product Market Share Analysis, 2018 & 2026

    • 5.2 Glucagon Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Glucagon Market: Application Analysis

    • 6.1 Glucagon Application Market Share Analysis, 2018 & 2026

    • 6.2 Glucagon Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Emergency Kits

      • 6.3.2 General Use

      • 6.3.3 Diagnostic & Motility

      • 6.3.4 Cardiogenic Shock

      • 6.3.5 Others

    7 Glucagon Market: Regional Analysis

    • 7.1 Glucagon Regional Market Share Analysis, 2018 & 2026

    • 7.2 Glucagon Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Torrent Labs

      • 9.1.1 Torrent Labs Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Eli Lilly

      • 9.2.1 Eli Lilly Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Xeris Pharmaceuticals

      • 9.3.1 Xeris Pharmaceuticals Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Novo Nordisk

      • 9.4.1 Novo Nordisk Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Fresenius Kabi

      • 9.5.1 Fresenius Kabi Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Taj Pharmaceuticals

      • 9.6.1 Taj Pharmaceuticals Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 64 Figures and 135 Tables)

    • Figure Inject Glucagon Glucagon market, 2015 - 2026 (USD Million)

    • Figure Nasal Glucagon Glucagon market, 2015 - 2026 (USD Million)

    • Figure Emergency Kits market, 2015 - 2026 (USD Million)

    • Figure General Use market, 2015 - 2026 (USD Million)

    • Figure Diagnostic & Motility market, 2015 - 2026 (USD Million)

    • Figure Cardiogenic Shock market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Glucagon market, by country, 2015 - 2026 (USD Million)

    • Table North America Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table North America Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table North America Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Canada Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Canada Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Europe Glucagon market, by country, 2015 - 2026 (USD Million)

    • Table Europe Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Europe Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Europe Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Germany Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Germany Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table France Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table France Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Italy Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Italy Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Spain Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Spain Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Glucagon market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table China Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table China Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Japan Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Japan Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table India Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table India Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Glucagon market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table MEA Glucagon market, by country, 2015 - 2026 (USD Million)

    • Table MEA Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table MEA Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table MEA Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Glucagon market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Glucagon market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Glucagon market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Torrent Labs Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Xeris Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fresenius Kabi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Taj Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US